The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

CEO Chris Ehrlich expressed optimism about the company's trajectory, stating that the improved financial outlook ... Therapeutics to begin Phase 1 clinical trials for its leading drug candidate ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

SOUTH SAN FRANCISCO - CERo Therapeutics Holdings, Inc. (NASDAQ:CERO), an immunotherapy company specializing in engineered T cell therapeutics, has announced a series of strategic moves aimed at ...

The famed cherry blossoms on the University of Washington campus in Seattle. (GeekWire File Photo / Kurt Schlosser) The fight ...

Use Click COI to disclose your financial interests and obligations as well as your sponsored travel. It allows for real-time updates throughout the year, so you can easily add new significant ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against the other cheap ...

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

In parallel with clinical advancements ... seeking deeper insights can access the comprehensive Pro Research Report available exclusively on InvestingPro, covering detailed analysis of BTAI's ...